5.07
price down icon1.55%   -0.08
after-market Dopo l'orario di chiusura: 5.07
loading

Bolt Biotherapeutics Inc Azioni (BOLT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
47.63%
1.804
1.222 - 1.141 1.275
Operating Expenses
17.42%
11.01
13.34 16.92 17.58 23.87
Benefits Costs and Expenses
100.00%
-
12.26 15.94 - -
Costs And Expenses
10.18%
11.01
12.26 15.94 17.58 23.87
Operating Income/Loss
23.98%
-9.21
-12.12 -16.92 -16.44 -22.60
Nonoperating Income/Loss
39.63%
0.649
1.075 0.98 1.267 1.402
Income/Loss From Continuing Operations Before Tax
116.34%
1.804
-11.04 -15.94 1.141 1.275
Income/Loss From Continuing Operations After Tax
22.45%
-8.561
-11.04 -15.94 -15.18 -21.20
Net Income/Loss
22.45%
-8.561
-11.04 -15.94 -15.18 -21.20
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
95.00%
1.9176
38.34 0.0341 38.25 38.13
Diluted Average Shares
95.00%
1.9176
38.34 0.0341 38.25 38.13
Basic Earnings Per Share
1,438%
-4.46
-0.29 -0.41 -0.40 -0.56
Diluted Earnings Per Share
1,438%
-4.46
-0.29 -0.41 -0.40 -0.56
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.92
price down icon 1.18%
$84.92
price down icon 2.30%
$26.29
price down icon 1.50%
$127.27
price down icon 0.41%
$112.55
price down icon 0.85%
biotechnology ONC
$319.32
price down icon 0.63%
Capitalizzazione:     |  Volume (24 ore):